Results 221 to 230 of about 4,894,740 (406)

Patient-Derived Organoids Predict Chemoradiation Responses of Locally Advanced Rectal Cancer.

open access: yesCell Stem Cell, 2019
Ye Yao   +27 more
semanticscholar   +1 more source

Neoadjuvant chemoradiotherapy with capecitabine and irinotecan guided by UGT1A1 status in patients with locally advanced rectal cancer: 5‐year update of the CinClare trial

open access: yesCancer Communications, EarlyView.
Abstract Background The optimal regimen and chemotherapy intensity are still under investigation for neoadjuvant treatment of locally advanced rectal cancer (LARC). The CinClare trial has demonstrated improved pathologic complete response (pCR) with the addition of irinotecan to neoadjuvant chemoradiotherapy (CRT) guided by uridine diphosphate ...
Zhen Zhang   +24 more
wiley   +1 more source

Optimizing rectal cancer surgery. [PDF]

open access: yesProc (Bayl Univ Med Cent)
Lichliter WE.
europepmc   +1 more source

A new approach to adjuvant radiotherapy in rectal cancer

open access: bronze, 1978
M. Mohiuddin, R. Dobelbower, S. Kramer
openalex   +1 more source

Risk of colorectal cancer by family history of both colorectal carcinomas and colorectal polyps: a nationwide cohort study

open access: yesCancer Communications, EarlyView.
Abstract Background The increased risk of colorectal cancer (CRC) associated with family history of both colorectal in situ or invasive carcinomas (Stage 0 to IV) and colorectal polyps is attributed solely to family history of CRC, resulting in an underestimation of the actual risk. We aimed to assess the association between overall and early‐onset CRC
Yuqing Hu   +6 more
wiley   +1 more source

Organ preservation in rectal cancer: opportunity within boundaries. [PDF]

open access: yesInt J Colorectal Dis
Cantagalli MM   +3 more
europepmc   +1 more source

Preoperative Irradiation for Rectal Cancer

open access: green, 1989
Ira J. Kodner   +6 more
openalex   +2 more sources

RNA m1A methyltransferase TRMT61A promotes colorectal tumorigenesis by enhancing ONECUT2 mRNA stability and is a potential therapeutic target

open access: yesCancer Communications, EarlyView.
Abstract Background The role of N1‐methyladenosine (m1A) in cancer is poorly understood. Here we explored the function of RNA methyltransferase TRNA methyltransferase 61A (TRMT61A) in colorectal cancer (CRC) and its potential as a therapeutic target. Methods RNA m1A levels were assessed through liquid chromatography‐mass spectrometry.
Xiaoting Zhang   +18 more
wiley   +1 more source

Home - About - Disclaimer - Privacy